Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 189 | 11p15.5 | HRAS | HRas proto-oncogene, GTPase | |
Mouse | - | 189 | 7 86.48 cM | Hras | Harvey rat sarcoma virus oncogene | |
Rat | - | 189 | 1q41 | Hras | HRas proto-oncogene, GTPase | |
Gene and Protein Information Comments | ||||||
Three isoforms have been identified for human HRAS. Isoforms 1 and 3 are both 189 amino acids long, but isoform 2 (NP_789765) is shorter (170 amino acids) and has a distinct C-terminus. The mouse protein also has three isoforms, 1 and 2 are 189 amino acids long and isoform 2 (NP_001123916) is 188 amino acids. Two transcripts have been identified in the rat, both produce identical proteins of 189 amino acids. |
Previous and Unofficial Names |
HRAS1 | transforming protein p21 | Harvey rat sarcoma viral oncogene homolog | Harvey rat sarcoma virus oncogene | HRas proto-oncogene, GTPase | HRas proto-oncogene |
Database Links | |
Alphafold | P01112 (Hs), Q61411 (Mm), P20171 (Rn) |
ChEMBL Target | CHEMBL2167 (Hs) |
Ensembl Gene | ENSG00000174775 (Hs), ENSMUSG00000025499 (Mm), ENSRNOG00000016611 (Rn) |
Entrez Gene | 3265 (Hs), 15461 (Mm), 293621 (Rn) |
Human Protein Atlas | ENSG00000174775 (Hs) |
KEGG Gene | hsa:3265 (Hs), mmu:15461 (Mm), rno:293621 (Rn) |
OMIM | 190020 (Hs) |
Pharos | P01112 (Hs) |
RefSeq Nucleotide | NM_005343 (Hs), NM_176795 (Hs), NM_001130442 (Hs), NM_001130443 (Mm), NM_001130444 (Mm), NM_008284 (Mm), NM_001098241 (Rn), NM_001130441 (Rn) |
RefSeq Protein | NP_001123914 (Hs), NP_789765 (Hs), NP_005334 (Hs), NP_001123915 (Mm), NP_032310 (Mm), NP_001123916.1 (Mm), NP_001091711 (Rn), NP_001123913 (Rn) |
UniProtKB | P01112 (Hs), Q61411 (Mm), P20171 (Rn) |
Wikipedia | HRAS (Hs) |
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||
|
Immuno Process Associations | ||
|
||
|
||
|
||
|
||
|
||
|
||
|
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
||||||||||||||
|
1. Liu M, Bryant MS, Chen J, Lee S, Yaremko B, Lipari P, Malkowski M, Ferrari E, Nielsen L, Prioli N et al.. (1998) Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice. Cancer Res, 58 (21): 4947-56. [PMID:9810004]